The New York powerhouse has agreed to surrender its 11.7% interest in the HIV-focused company for $1.875 billion. Under terms ...
The GSK (LSE:GSK) share price has fallen considerably since the company’s demerger with its consumer healthcare arm Haleon in July 2022. However, the stock did surge around 7.5% at the end of April ...